Rothstein B. Topical JAK inhibitor Ruxolitinib for Vitiligo Treatment. J of Skin [Internet]. 2018Dec.17 [cited 2024Jul.22];2:S110-S111. Available from: https://jofskin.org/index.php/skin/article/view/451